|
Market Closed -
OTC Markets
14:32:11 30/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 8.200 USD | +18.84% |
|
+18.84% | +9.33% |
| 09-18 | Redcare extend gains, Deutsche Bank view and chart provide support | DP |
| 09-18 | Redcare Pharmacy NV : Deutsche Bank gives a Buy rating | ZD |
Company Valuation: Redcare Pharmacy NV
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,050 | 798.2 | 2,395 | 2,679 | 1,324 | 1,416 | - | - |
| Change | - | -61.07% | 200.06% | 11.86% | -50.57% | 6.91% | - | - |
| Enterprise Value (EV) 1 | 2,039 | 986.6 | 2,556 | 2,830 | 1,648 | 1,650 | 1,638 | 1,601 |
| Change | - | -51.62% | 159.04% | 10.72% | -41.74% | 0.06% | -0.73% | -2.25% |
| P/E | -27.3x | -10.2x | -180x | -58x | -34.8x | -152x | 59.8x | 25.1x |
| PBR | 4.94x | 2.26x | 5.09x | 5.54x | 2.85x | 2.94x | 2.8x | 2.51x |
| PEG | - | -2.49x | 2.2x | -0x | 2x | 2x | -0x | 0x |
| Capitalization / Revenue | 1.93x | 0.66x | 1.33x | 1.13x | 0.45x | 0.41x | 0.37x | 0.33x |
| EV / Revenue | 1.92x | 0.82x | 1.42x | 1.19x | 0.56x | 0.48x | 0.43x | 0.38x |
| EV / EBITDA | -408x | -123x | 47.8x | 85x | 28.7x | 17.2x | 12.6x | 9.73x |
| EV / EBIT | -63.1x | -20.7x | -674x | -81x | -135x | 62.2x | 27.6x | 17.1x |
| EV / FCF | -64.7x | -11.9x | 110x | -141x | -18.8x | -38.3x | 139x | 36.1x |
| FCF Yield | -1.55% | -8.38% | 0.91% | -0.71% | -5.31% | -2.61% | 0.72% | 2.77% |
| Dividend per Share 2 | - | - | - | - | - | 0.00667 | - | - |
| Rate of return | - | - | - | - | - | 0.01% | - | - |
| EPS 2 | -4.15 | -4.32 | -0.73 | -2.27 | -1.87 | -0.454 | 1.151 | 2.74 |
| Distribution rate | - | - | - | - | - | -1.47% | - | - |
| Net sales 1 | 1,060 | 1,204 | 1,799 | 2,371 | 2,941 | 3,437 | 3,840 | 4,236 |
| EBITDA 1 | -5 | -8.044 | 53.5 | 33.3 | 57.4 | 95.66 | 129.4 | 164.5 |
| EBIT 1 | -32.3 | -47.55 | -3.793 | -34.91 | -12.2 | 26.54 | 59.37 | 93.57 |
| Net income 1 | -74.2 | -77.65 | -12.04 | -45.46 | -37.7 | -9.239 | 24.04 | 59.1 |
| Net Debt 1 | -10.98 | 188.4 | 160.7 | 150.5 | 324.2 | 233.7 | 221.7 | 184.9 |
| Reference price 2 | 113.30 | 44.11 | 131.60 | 131.70 | 65.10 | 68.80 | 68.80 | 68.80 |
| Nbr of stocks (in thousands) | 18,095 | 18,095 | 18,199 | 20,342 | 20,342 | 20,578 | - | - |
| Announcement Date | 02/03/22 | 07/03/23 | 05/03/24 | 11/03/25 | 03/03/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 16.41x | 0.65x | 9.71x | -.--% | 14.63B | |
| 21.92x | 0.9x | 9.56x | 2.02% | 6.27B | |
| 20.05x | 0.34x | 5.41x | 2.3% | 6.03B | |
| 15.85x | 0.71x | 7.36x | 2.35% | 6.11B | |
| 19.37x | 0.72x | 12.2x | 1.12% | 5.9B | |
| 14.99x | 0.92x | 6.46x | 2.82% | 4.21B | |
| 14.25x | 1.23x | 7.55x | 5.68% | 3.15B | |
| 15.34x | 0.44x | 7.38x | 1.37% | 3.13B | |
| 13.96x | 0.59x | 4.54x | 5.17% | 3.09B | |
| Average | 16.90x | 0.72x | 7.80x | 2.54% | 5.84B | |
| Weighted average by Cap. | 17.30x | 0.70x | 8.37x | 1.86% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RDC Stock
- SAEYY Stock
- Valuation Redcare Pharmacy NV
Select your edition
All financial news and data tailored to specific country editions
